INTERIM RESULTS
11th September 2007
A solid platform for a strong full year
Cello Group plc (“Cello”, AIM: CLL. “The Group”), the market research and consulting group, today announces its interim results for the 6 month period to 30 June 2007.
Financial Highlights
• Turnover up 44% to £45.8m (2006: £31.7m)
• Operating income up 38% to £24.4m (2006: £17.7m)
• Headline profit before tax up 19% to £3.1m (2006: £2.6m)
• Like-for-like operating income growth of 20%
• Like-for-like operating profit growth of 6%
• Basic headline earnings per share up 15% to 6.42p (2006: 5.60p)
• Interim dividend up 12.5% to 0.45p (2006: 0.4p)
Operational Highlights
• Continued organic revenue growth fuelled by large contract wins
• Invested heavily to increase organic professional headcount by 15%
• Three acquisitions completed
– Rosenblatt/Digital People, a qualitative market research agency
– MSI, a leading healthcare research consultancy
– mruk research, a public sector market research specialist agency
Kevin Steeds, Chairman, commented:
“During the last six months we have continued our focused strategy – to make highly selective acquisitions and invest heavily in people to support our growth.
“As we approach the end of our third full year as a public company, we have much to be proud of. Cello is now firmly established as a leading research and consulting business, with an outstanding group of 650 professionals, a roster of blue-chip global clients, and prudent financing. We now move forward from a position of strength.”
Contact Us
Address
Cello Health plc
Queens House
8-9 Queen Street
London
EC4N 1SP
Registered Office
Queens House
8-9 Queen Street
London
EC4N 1SP
Company Registered
in England no.05120150